Rodman & Renshaw just downgraded shares of Clinical Data (NASDAQ: CLDA) from Market Outperform to Market Perform following news ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE